Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W
Department of Medicine, Jagellonian University School of Medicine, Cracow, Poland.
Br J Haematol. 2000 Sep;110(4):965-7. doi: 10.1046/j.1365-2141.2000.02267.x.
A single nucleotide T to C transition of the gene encoding glycoprotein IIIa leads to a common diallelic polymorphism Leu-33-->Pro (PLA1/A2). We studied the relationship between the PlA1/A2 polymorphism and platelet function in 80 healthy men, aged 20-25 years. Before aspirin ingestion, bleeding time (BT) was shorter in carriers of the PlA2 than in carriers of the PlA1/A1 allele. At 4 h after ingestion of 300 mg of aspirin, BT became prolonged, and the intergroup difference was enhanced. In seven out of 26 PLA2 allele carriers, aspirin shortened BT on average by 30 s, compared with only one among 54 subjects with the PlA1/A1 genotype. Thus, BT both at baseline and after aspirin depends on the PlA1/A2 polymorphism of glycoprotein IIIa. Carriers of the PlA2 allele appear to be more resistant to the antithrombotic action of aspirin.
编码糖蛋白IIIa的基因发生单个核苷酸T到C的转变,导致常见的双等位基因多态性Leu-33→Pro(PLA1/A2)。我们研究了80名年龄在20至25岁之间的健康男性中PlA1/A2多态性与血小板功能之间的关系。在服用阿司匹林之前,PlA2携带者的出血时间(BT)比PlA1/A1等位基因携带者短。在摄入300毫克阿司匹林4小时后,BT延长,组间差异增大。在26名PlA2等位基因携带者中有7人,阿司匹林使BT平均缩短30秒,而在54名PlA1/A1基因型受试者中只有1人出现这种情况。因此,基线时和服用阿司匹林后的BT均取决于糖蛋白IIIa的PlA1/A2多态性。PlA2等位基因携带者似乎对阿司匹林的抗血栓作用更具抗性。